ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,293 | +4.9% | 174 | 0.0% | 0.00% | – |
| Q2 2023 | $15,530 | +5.7% | 174 | +27.0% | 0.00% | – |
| Q1 2023 | $14,689 | -12.2% | 137 | 0.0% | 0.00% | – |
| Q4 2022 | $16,732 | +39.4% | 137 | +20.2% | 0.00% | – |
| Q3 2022 | $12,000 | +50.0% | 114 | +34.1% | 0.00% | – |
| Q2 2022 | $8,000 | -27.3% | 85 | -5.6% | 0.00% | – |
| Q1 2022 | $11,000 | +120.0% | 90 | +157.1% | 0.00% | – |
| Q4 2021 | $5,000 | -16.7% | 35 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | +20.0% | 35 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | 0.0% | 35 | +12.9% | 0.00% | – |
| Q4 2020 | $5,000 | +66.7% | 31 | +82.4% | 0.00% | – |
| Q3 2020 | $3,000 | 0.0% | 17 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 17 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 17 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |